CD14 positivity significantly decreased in single- and mixed-stain groups when compared with the NASH group (18.00 ± 1.00 vs. 29.00 ± 5.00 vs. 60.00 ± 9.00, respectively; p < 0.05). Here, CD14 is linked to metabolic dysfunction-associated steatohepatitis.